Connexin 43 Hemichannels and Signaling In Bone

Connexin 43 半通道和骨信号传导

基本信息

项目摘要

DESCRIPTION (provided by applicant): Connexins (Cx) are a family of proteins essential for cell-to-cell communication and for the communication of cells with their environment. Cx43 is the most abundant connexin expressed in bone cells. The importance of Cx43 expression in the skeleton has been established by the demonstration of the osteoblast dysfunction and delay ossification in embryos of Cx43 null mice. However, the role of Cx43 and, in particular Cx43 hemichannels expressed in unopposed cell membranes, is far from being completely understood. In studies leading to this application it was demonstrated that bisphosphonates, besides stopping osteoclast-mediated resorption, might preserve bone strength at least in part by promoting osteoblast and osteocyte viability and that Cx43 expression is required for this survival effect. Thus, inhibition of apoptosis by bisphosphonates requires opening of Cx43 hemichannels, activation of the extracellular signal-regulated kinases (ERKs) and extra-nuclear retention of the kinases due to their interaction with the scaffolding protein (-arrestin. Cx43 is also required for prevention of osteoblast apoptosis by parathyroid hormone (PTH) in vitro; and the anabolic response to intermittent administration of the hormone is blunted in mice deficient mice in Cx43. In addition, Cx43 might be also involved in mechanotransduction in the skeleton. Thus, mechanical stimulation increases Cx43 expression, gap junction communication and hemichannel opening in osteoblasts and osteocytes. Based on this evidence, it is hypothesized that Cx43 is a crucial component of signaling pathways activated by pharmacologic, hormonal and mechanical stimuli in osteoblasts and osteocytes, via its involvement in hemichannels or gap junctions or its scaffolding properties. This hypothesis will be tested by a combination of in vitro and in vivo approaches. Studies in Aim 1 will examine the in vivo relevance of the Cx43/(-arrestin/ERK pathway for bisphosphonate actions on bone using bisphosphonate analogs that selectively activate this pathway; and they will delineate the mechanism by which association of Cx43, ERKs and (-arrestin leads to retention of ERKs outside the nucleus and the internalization of Cx43. Studies in Aim 2 will determine the role of Cx43 in the anti-apoptotic effect of PTH in vivo by examining whether the lack of anabolic effect of intermittent PTH administration to mice deficient in Cx43 is due to the inability of PTH to prevent osteoblast apoptosis. Aim 3 will define the role of Cx43 hemichannels in mechanotransduction in vivo and in vitro. This will be accomplished by investigating whether changes in gene expression and the anabolic response to mechanical loading are altered in Cx43 deficient mice; and whether Cx43 is required for the effects of mechanical stimulation in osteoblasts and osteocytes in vitro. We expect that this work will provide opportunities to improve the treatment of diseases with increased bone fragility. PUBLIC HEALTH RELEVANCE: These studies will advance our understanding of the role of Cx43 in the response of the skeleton to pharmacotherapeutic, hormonal and mechanical stimuli. We expect that this work will provide opportunities to improve the treatment of diseases with increased bone fragility.
描述(由申请人提供):连接蛋白(Cx)是细胞间通讯以及细胞与其环境通讯所必需的蛋白质家族。Cx43是骨细胞中表达最丰富的连接蛋白。Cx43表达在骨骼中的重要性已经通过Cx43缺失小鼠胚胎中成骨细胞功能障碍和延迟骨化的证明而确立。然而,Cx43的作用,特别是Cx43半通道在非对立的细胞膜中表达,是远远没有被完全理解。在导致该应用的研究中,证明了双膦酸盐除了阻止破骨细胞介导的再吸收之外,还可以通过促进成骨细胞和骨细胞活力至少部分地保持骨强度,并且这种存活效应需要Cx43表达。因此,通过二膦酸盐抑制细胞凋亡需要Cx43半通道的打开、细胞外信号调节激酶(ERK)的激活以及由于它们与支架蛋白(β-arrestin)的相互作用而导致的激酶的核外保留。Cx43也需要在体外通过甲状旁腺激素(PTH)预防成骨细胞凋亡;在Cx43缺陷小鼠中,对间歇性给予激素的合成代谢反应减弱。此外,Cx43还可能参与骨骼中的机械传导。因此,机械刺激增加成骨细胞和骨细胞中的Cx43表达、间隙连接通讯和半通道开放。基于这一证据,假设Cx43是成骨细胞和骨细胞中由药理学、激素和机械刺激激活的信号通路的关键组分,通过其参与半通道或间隙连接或其支架特性。该假设将通过体外和体内方法的组合进行检验。目的1中的研究将使用选择性激活该途径的双膦酸盐类似物来检查Cx43/β-arrestin/ERK途径对于双膦酸盐对骨的作用的体内相关性;并且它们将描述Cx43、ERK和β-arrestin的结合导致ERK保留在核外和Cx43内化的机制。目的2中的研究将通过检查对Cx43缺陷的小鼠间歇性施用PTH缺乏合成代谢作用是否是由于PTH不能防止成骨细胞凋亡,来确定Cx43在PTH体内抗凋亡作用中的作用。目的3明确Cx43半通道在体内外机械力信号转导中的作用。这将通过研究Cx43缺陷小鼠中基因表达的变化和对机械负荷的合成代谢反应是否改变来实现;以及Cx43是否是体外成骨细胞和骨细胞中机械刺激作用所必需的。我们希望这项工作将为改善骨脆性增加疾病的治疗提供机会。公共卫生关系:这些研究将促进我们对Cx43在骨骼对药物、激素和机械刺激的反应中的作用的理解。我们希望这项工作将为改善骨脆性增加疾病的治疗提供机会。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Lilian Irene Plotkin其他文献

Lilian Irene Plotkin的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Lilian Irene Plotkin', 18)}}的其他基金

Contribution of chromosome versus gonadal sex to bone mass and strength
染色体与性腺性别对骨量和强度的贡献
  • 批准号:
    10508931
  • 财政年份:
    2022
  • 资助金额:
    $ 31.57万
  • 项目类别:
Contribution of chromosome versus gonadal sex to bone mass and strength
染色体与性腺性别对骨量和强度的影响
  • 批准号:
    10666647
  • 财政年份:
    2022
  • 资助金额:
    $ 31.57万
  • 项目类别:
Contribution of chromosome versus gonadal sex to bone mass and strength
染色体与性腺性别对骨量和强度的贡献
  • 批准号:
    10711910
  • 财政年份:
    2022
  • 资助金额:
    $ 31.57万
  • 项目类别:
Skeletal complications to a TREM2 variant associated with Alzheimer's Disease
与阿尔茨海默病相关的 TREM2 变异的骨骼并发症
  • 批准号:
    10408018
  • 财政年份:
    2021
  • 资助金额:
    $ 31.57万
  • 项目类别:
Skeletal complications to a TREM2 variant associated with Alzheimer's Disease
与阿尔茨海默病相关的 TREM2 变异的骨骼并发症
  • 批准号:
    10259555
  • 财政年份:
    2021
  • 资助金额:
    $ 31.57万
  • 项目类别:
Skeletal complications to a TREM2 variant associated with Alzheimer's Disease
与阿尔茨海默病相关的 TREM2 变异的骨骼并发症
  • 批准号:
    10618952
  • 财政年份:
    2021
  • 资助金额:
    $ 31.57万
  • 项目类别:
Osteocyte Apoptosis and Regulation of Bone Resorption with Aging
骨细胞凋亡和骨吸收随衰老的调节
  • 批准号:
    9212771
  • 财政年份:
    2015
  • 资助金额:
    $ 31.57万
  • 项目类别:
Osteocyte apoptosis and regulation of bone resorption with aging
衰老过程中骨细胞凋亡和骨吸收的调节
  • 批准号:
    9308117
  • 财政年份:
    2015
  • 资助金额:
    $ 31.57万
  • 项目类别:
Connexin 43 Hemichannels and Signaling In Bone
Connexin 43 半通道和骨信号传导
  • 批准号:
    8241176
  • 财政年份:
    2008
  • 资助金额:
    $ 31.57万
  • 项目类别:
Connexin 43 Hemichannels and Signaling In Bone
Connexin 43 半通道和骨信号传导
  • 批准号:
    7658224
  • 财政年份:
    2008
  • 资助金额:
    $ 31.57万
  • 项目类别:

相似国自然基金

Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
  • 批准号:
    LBY21H010001
  • 批准年份:
    2020
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
  • 批准号:
    81703335
  • 批准年份:
    2017
  • 资助金额:
    20.0 万元
  • 项目类别:
    青年科学基金项目
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
  • 批准号:
    81670594
  • 批准年份:
    2016
  • 资助金额:
    58.0 万元
  • 项目类别:
    面上项目
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
  • 批准号:
    81470791
  • 批准年份:
    2014
  • 资助金额:
    73.0 万元
  • 项目类别:
    面上项目
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
  • 批准号:
    81301123
  • 批准年份:
    2013
  • 资助金额:
    23.0 万元
  • 项目类别:
    青年科学基金项目
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
  • 批准号:
    81101529
  • 批准年份:
    2011
  • 资助金额:
    22.0 万元
  • 项目类别:
    青年科学基金项目
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
  • 批准号:
    39500043
  • 批准年份:
    1995
  • 资助金额:
    9.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Spatial Restriction of Apoptotic Machinery during Neuronal Apoptosis and Pruning
神经元凋亡和修剪过程中凋亡机制的空间限制
  • 批准号:
    10596657
  • 财政年份:
    2021
  • 资助金额:
    $ 31.57万
  • 项目类别:
Spatial Restriction of Apoptotic Machinery during Neuronal Apoptosis and Pruning
神经元凋亡和修剪过程中凋亡机制的空间限制
  • 批准号:
    10417219
  • 财政年份:
    2021
  • 资助金额:
    $ 31.57万
  • 项目类别:
Examining the contribution of apoptosis repressor with caspase recruitment domain (ARC) to the anti-apoptotic effect of endurance training in skeletal muscle
检查具有半胱天冬酶募集结构域 (ARC) 的凋亡抑制因子对骨骼肌耐力训练的抗凋亡作用的贡献
  • 批准号:
    441952-2013
  • 财政年份:
    2015
  • 资助金额:
    $ 31.57万
  • 项目类别:
    Alexander Graham Bell Canada Graduate Scholarships - Doctoral
Examining the contribution of apoptosis repressor with caspase recruitment domain (ARC) to the anti-apoptotic effect of endurance training in skeletal muscle
检查具有半胱天冬酶募集结构域 (ARC) 的凋亡抑制因子对骨骼肌耐力训练的抗凋亡作用的贡献
  • 批准号:
    441952-2013
  • 财政年份:
    2014
  • 资助金额:
    $ 31.57万
  • 项目类别:
    Alexander Graham Bell Canada Graduate Scholarships - Doctoral
Understanding the activation of pro-apoptotic Bcl-2 family proteins for the development of modulators of apoptosis
了解促凋亡 Bcl-2 家族蛋白的激活以开发凋亡调节剂
  • 批准号:
    nhmrc : 1059331
  • 财政年份:
    2014
  • 资助金额:
    $ 31.57万
  • 项目类别:
    Project Grants
Examining the contribution of apoptosis repressor with caspase recruitment domain (ARC) to the anti-apoptotic effect of endurance training in skeletal muscle
检查具有半胱天冬酶募集结构域 (ARC) 的凋亡抑制因子对骨骼肌耐力训练的抗凋亡作用的贡献
  • 批准号:
    441952-2013
  • 财政年份:
    2013
  • 资助金额:
    $ 31.57万
  • 项目类别:
    Postgraduate Scholarships - Doctoral
Apoptotic Osteocytes Promote Chondrocyte Apoptosis via Soluble Factors
凋亡骨细胞通过可溶性因子促进软骨细胞凋亡
  • 批准号:
    251802
  • 财政年份:
    2012
  • 资助金额:
    $ 31.57万
  • 项目类别:
    Studentship Programs
Defining the mechanism(s) by which the cellular inhibitor of apoptosis protein 2 (cIAP2) contributes to early stage atherosclerosis development by directly promoting the participation of key apoptotic pathways within lesion-associated macrophages
确定凋亡蛋白细胞抑制剂 2 (cIAP2) 通过直接促进病变相关巨噬细胞内关键凋亡途径的参与来促进早期动脉粥样硬化发展的机制
  • 批准号:
    191299
  • 财政年份:
    2009
  • 资助金额:
    $ 31.57万
  • 项目类别:
    Operating Grants
ATP release during apoptosis and its relevance to apoptotic cell clearance
凋亡过程中 ATP 释放及其与凋亡细胞清除的相关性
  • 批准号:
    8075522
  • 财政年份:
    2009
  • 资助金额:
    $ 31.57万
  • 项目类别:
ATP release during apoptosis and its relevance to apoptotic cell clearance
凋亡过程中 ATP 释放及其与凋亡细胞清除的相关性
  • 批准号:
    7676912
  • 财政年份:
    2009
  • 资助金额:
    $ 31.57万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了